| | |
|
| |
| | |
|
|
BPI A-Hd 250 Mg (28 Caps)
|
|
MSRP: $56.99
Price: $34.99
In stock
|
Anti-Aromatase Testosterone Booster. Advanced Bio-Lipid Delivery Matrix. Ultra-Concentrated Testosterone Booster. A-HD is intended to promote a Shredded, Harder, More Dry Looking Physique. It works by increases free Testosterone Levels while minimizing Estrogens. A-HD- a novel compound Testosterone Boosting Agent. A shut down Anti-Aromatase Inhibitor. For Athlete Use Only. 250 mg.
Directions
Take one (1) capsule daily, at the same time each day, or as directed by a qualified healthcare practitioner. For best results take four to eight (4-8) consecutive weeks (1-2 Cycles). Do not take this product longer than 8 consecutive weeks. A four (4) week break between cycles is recommended.
Warnings
Consult with a licensed physician before using this product. Do not take this product if you have prostate hypertrophy, liver disease, kidney or heart disease, or are being treated for any medical condition. This product should not be taken by women. In particular, those women who are pregnant, lactating or trying to become pregnant, should not take this product. Do not take this product if you have been diagnosed with elevated cholesterol, prostate cancer, testicular cancer or breast cancer, or are under the age of 18. Keep this product and all supplements out of the reach of children. Must be 18 years of age or older to purchase this product. The ingredients in A-HD may cause false positives for banned substances by many sports and governmental agencies. Do Not use this product if you are being tested for any banned substances.
|
Nutrition Facts †
Serving Size 1 Capsule
Servings Per Container 28
|
|
|
|
Amount Per Serving
|
|
|
|
|
Serving
|
% DV
|
|
Niacin (as nicotinic acid, USP)
|
25.0 mg
|
125%
|
|
|
|
Niacin (as Nicotinic Acid, USP)
|
25.0 mg
|
125%
|
|
|
|
Proprietary Blend
|
250.0 mg
|
-
|
|
|
|
|
|
Proprietary Blends
|
|
|
|
Proprietary Blend
(3s,4s)-4-((3,4-dimethoxyphenyl)methyl)-3-hydroxy-3-((3-methoxy-4-(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-phenyl)methyl)oxolan-2-one. (2r,3r)-2,3-bis((4-hydroxy-3-methoxyphenyl)methyl)butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol. (s)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone. 4-((e)-2-(3,5-dimethoxyphenyl)ethenyl)phenol. phenethyl(e)-3-(3,4-dihydroxyphenyl)prop-2-enoate. Standardized Phytochemical Complex: Cynara cardunculus (leaf); Curcuma longa (rhizome); Capsicum annuum (whole plant); Pelargonium graveolens (whole plant).
|
|
|
|
|
|
*percent Daily Values are based on a 2,000 calorie diet.
|
|
|
|
|
|
Ingredients: Gelatin, Microcrystalline Cellulose, Magnesium Stearate, Silicon Dioxide, Hypromellose, Polyvinylpyrrolidone, Maltodextrin.
|
|
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
†Nutritions Facts are a simulation of the product "Nutrition Label". For the actual Nutrition Label please refer to the product packaging.
|
BPI A-HD ingredients by common names:
*(3s,4s)-4-[(3,4-dimethoxyphenyl)methyl]-3-hydroxy-3-[[3-methoxy-4-[(2s,3r,4s,5r,6r)-3, 4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-phenyl]methyl]oxolan-2-one: is tracheloside http://www.ncbi.nlm.nih.gov/pubmed/17090940
*(2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl] butane-1,4-diol;(2r,3r,4s,5s,6r)- 6-(hydroxymethyl)oxane-2,3,4,5-tetro:l is Secoisolariciresinol diglycoside which is a flaxseed lignan and phytoestrogen. http://www.ncbi.nlm.nih.gov/pubmed/20432175
*4-[(e)-2-(3,5-dimethoxyphenyl)ethenyl]phenol: is a Pterostilbene which is a Stilbenoid, a close cousin of Resveratrol found in grapes. http://www.ncbi.nlm.nih.gov/pubmed/21056131 **Looks like it works if your also taking Nolvadex
*s)-5-hydroxy-1-(4-hydroxy-3-methoxyphenyl)-3-decanone: is Gingerol comes from Ginger, there one study showing how it upregulated depleted testosterone levels in mice with prostate cancer
*phenethyl(e)-3-(3,4-dihydroxyphenyl)prop-2-enoate: is Caffeic Acid phenethyl ester http://www.ncbi.nlm.nih.gov/pubmed/19655397
Phytother Res. 2010 Feb;24(2):295-300.
Caffeic acid phenethyl ester, a component of beehive propolis, is a novel selective estrogen receptor modulator.
Jung BI, Kim MS, Kim HA, Kim D, Yang J, Her S, Song YS.
College of Pharmacy, Sookmyung Women’s University, Seoul, Republic of Korea.
Abstract
Caffeic acid phenethyl ester (CAPE) is an active ingredient of beehive propolis with a structure similar to phenolic acid. The estrogenic effects of propolis were previously demonstrated through the activation of an estrogen receptor. To identify the estrogenic properties of propolis, CAPE was evaluated using in vitro and in vivo methods. CAPE showed selective binding affinity to human estrogen receptor beta (hERbeta) rather than hERalpha. CAPE also reduced ERalpha expression in MCF-7 and MDA 231 cells. In the yeast estrogen receptor transcription assay, CAPE produced the transcriptional activity of estrogen-responsive element with EC(50) values of 3.72 x 10(-6) M. CAPE did not increase the growth of MCF-7 estrogen receptor-positive breast cancer cells in doses ranging from 10(-7) to 10(-5) M. In order to understand how CAPE acts in animals, CAPE was tested by a uterotrophic bioassay. Treatment with CAPE (100, 500 mg/kg) did not increase the uterine weight relative to 3 microg/kg 17beta-estradiol treatment. The results indicate that CAPE, which is a selective agonist to hERbeta, but does not show any estrogenic effect on estrogen receptor-positive breast cancer cells and in immature rat uterine tissue, is a potential selective estrogen receptor modulator. (c) 2009 John Wiley & Sons, Ltd.
PMID: 19655397 [PubMed - indexed for MEDLINE]
|
Phytother Res. 2010 Feb;24(2):295-300.
Caffeic acid phenethyl ester, a component of beehive propolis, is a novel selective estrogen receptor modulator.
Jung BI, Kim MS, Kim HA, Kim D, Yang J, Her S, Song YS.
College of Pharmacy, Sookmyung Women’s University, Seoul, Republic of Korea.
Abstract
Caffeic acid phenethyl ester (CAPE) is an active ingredient of beehive propolis with a structure similar to phenolic acid. The estrogenic effects of propolis were previously demonstrated through the activation of an estrogen receptor. To identify the estrogenic properties of propolis, CAPE was evaluated using in vitro and in vivo methods. CAPE showed selective binding affinity to human estrogen receptor beta (hERbeta) rather than hERalpha. CAPE also reduced ERalpha expression in MCF-7 and MDA 231 cells. In the yeast estrogen receptor transcription assay, CAPE produced the transcriptional activity of estrogen-responsive element with EC(50) values of 3.72 x 10(-6) M. CAPE did not increase the growth of MCF-7 estrogen receptor-positive breast cancer cells in doses ranging from 10(-7) to 10(-5) M. In order to understand how CAPE acts in animals, CAPE was tested by a uterotrophic bioassay. Treatment with CAPE (100, 500 mg/kg) did not increase the uterine weight relative to 3 microg/kg 17beta-estradiol treatment. The results indicate that CAPE, which is a selective agonist to hERbeta, but does not show any estrogenic effect on estrogen receptor-positive breast cancer cells and in immature rat uterine tissue, is a potential selective estrogen receptor modulator. (c) 2009 John Wiley & Sons, Ltd.
PMID: 19655397 [PubMed - indexed for MEDLINE]
|
|
Product Reviews
| (13 Ratings, 0 Reviews) |
Average Rating:
|
|
|
|